Serum Biotin Levels in General Korean Population
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The risk of biotin interference has been growing, as the intake of biotin for hair, skin, and nail care has increased. Elevated serum biotin concentraꠓtion can interfere with immunoassays, thereby possibly leading to serious medical problems. In this study, we estimated the risk of biotin interferꠓence by investigating the distribution of serum biotin concentration in the general population of Korea. From October 2020 to March 2021, 723 samples were collected from individuals (age: 18–81 years) who underwent a medical checkup. Biotin levels were quantified by liquid chromatogꠓraphy coupled with tandem mass spectrometry (LC-MS/MS). Biotin interference in the thyroid function test and vitamin D immunoassay was asꠓsessed for samples with biotin levels above 10 ng/mL. Thyroid function and vitamin D results obtained by a streptavidin-biotin-based electrochemiꠓluminescence immunoassay were compared to those of a chemiluminescent microparticle immunoassay and LC-MS/MS, respectively. A total of 0.41% (3/723) of samples showed serum biotin concentration above the lowest threshold (10 ng/mL) for biotin interference. Vitamin D status in a patient with serum biotin concentration of 130.3 ng/mL was normal according to the immunoassay (30.6 ng/mL) but deficient (29.3 ng/mL) acꠓcording to LC-MS/MS. Judging by the distribution of biotin concentration in the general population, the risk of biotin interference seems to be low in Korea. Further studies are needed to monitor biotin concentration because biotin intake is increasing
Abstract
The risk of biotin interference has been growing, as the intake of biotin for hair, skin, and nail care has increased. Elevated serum biotin concentraꠓtion can interfere with immunoassays, thereby possibly leading to serious medical problems. In this study, we estimated the risk of biotin interferꠓence by investigating the distribution of serum biotin concentration in the general population of Korea. From October 2020 to March 2021, 723 samples were collected from individuals (age: 18–81 years) who underwent a medical checkup. Biotin levels were quantified by liquid chromatogꠓraphy coupled with tandem mass spectrometry (LC-MS/MS). Biotin interference in the thyroid function test and vitamin D immunoassay was asꠓsessed for samples with biotin levels above 10 ng/mL. Thyroid function and vitamin D results obtained by a streptavidin-biotin-based electrochemiꠓluminescence immunoassay were compared to those of a chemiluminescent microparticle immunoassay and LC-MS/MS, respectively. A total of 0.41% (3/723) of samples showed serum biotin concentration above the lowest threshold (10 ng/mL) for biotin interference. Vitamin D status in a patient with serum biotin concentration of 130.3 ng/mL was normal according to the immunoassay (30.6 ng/mL) but deficient (29.3 ng/mL) acꠓcording to LC-MS/MS. Judging by the distribution of biotin concentration in the general population, the risk of biotin interference seems to be low in Korea. Further studies are needed to monitor biotin concentration because biotin intake is increasing
참고문헌 (14)
- Zempleni J, "Biotin biochemistry and human requirements", J Nutr Biochem, 10, pp.128~138 (1999)
- "UPDATE: The FDA warns that biotin may interfere with lab tests: FDA safety communication" (2019)[URL]
- Chun KY, "Biotin interference in diagnostic tests", Clin Chem, 63, pp.619~620 (2017)
- 박현아, "한국인은 어떤 건강기능식품을 복용하고 있는가? 2015년국민건강영양조사를 중심으", Korean Journal of Health Promotion, 18(3), pp.107~112 (2018), 대한임상건강증진학회[DOI]
- "Food and other production performance statistics in 2020" (2021)[URL]
- Gunsolus IL, "Prevalence of detectable biotin in five US emergency department patient cohorts", Clin Biochem, 93, pp.26~32 (2021)
- IJpelaar A, "Prevalence of detectable biotin in The Netherlands in relation to risk on immunoassay interference", Clin Biochem, 83, pp.78~80 (2020)
- Katzman BM, "Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department", Clin Biochem, 60, pp.11~16 (2018)
- Sanders A, "Biotin immunoassay interference : A UK-based prevalence study", Ann Clin Biochem, 58, pp.66~69 (2021)
- Trambas CM, "Further assessment of the prevalence of biotin supplementation and its impact on risk", Clin Biochem, 65, pp.64~65 (2019)
- Song DY, "Quantitative measurement of biotin by LC-MS", MS in human serum and the effect of multivitamin and renal function on biotin concentration, Seoul National University, 2019
- Li D, "AACC Guidance Document on Biotin Interference in Laboratory Tests", J Appl Lab Med, 5, pp.575~587 (2020)
- Piketty ML, "High-dose biotin therapy leading to false biochemical endocrine profiles : validation of a simple method to overcome biotin interference", Clin Chem Lab Med, 55, pp.817~825 (2017)
- Giovanella L, "The impact of biotin interference on laboratory testing and patient diagnosis in clinical practice", Int J Pharmacokinet, 4, pp.IPK01~ (2019)